GEORGE A HOLLAND
Medical Practice at Mckinley Rd, Marblehead, MA
License number
Florida 110826
Issued Date
Aug 10, 2011
Effective Date
Feb 18, 2016
Expiration Date
Jan 31, 2014
Category
Health Care
Type
Medical Doctor
Address
Address
2
16 Mckinley Rd, Marblehead, MA 01945
601 Elmwood Ave, Rochester, NY 14642
601 Elmwood Ave, Rochester, NY 14642
Phone
(339) 234-0518
Organization information
See more information about GEORGE A HOLLAND at bizstanding.comGeorge Holland MD
601 Elmwood Ave, Rochester, NY 14642
Industry:
Radiology
Phone:
(585) 341-4950 (Phone)
George Alan Holland
Strong Memorial Hospital - George A Holland MD
601 Elmwood Ave #648, Rochester, NY 14642
Categories:
Radiology Physicians & Surgeons
Phone:
(585) 275-5434 (Phone)
Professional information
Dr. George A Holland, Rochester NY - MD (Doctor of Medicine)
Specialties:
Diagnostic Radiology
Address:
601 Elmwood Ave, Rochester 14642
(585) 275-5434 (Phone)
(585) 275-5434 (Phone)
Certifications:
Diagnostic Radiology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
601 Elmwood Ave, Rochester 14642
Highland Hospital
1000 South Ave, Rochester 14620
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Highland Hospital
1000 South Ave, Rochester 14620
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
George A Holland, Rochester NY
Specialties:
Radiologist
Address:
601 Elmwood Ave, Rochester, NY 14642
Education:
Doctor of Medicine
Board certifications:
American Board of Radiology Certification in Diagnostic Radiology (Radiology)
George Holland, Rochester NY
Work:
Strong Memorial Hospital
601 Elmwood Ave, Rochester, NY 14642
601 Elmwood Ave, Rochester, NY 14642
Reducing Risk Of Complications Associated With Tissue Ablation
US Patent:
2012025, Oct 4, 2012
Filed:
Mar 29, 2012
Appl. No.:
13/434750
Inventors:
George A. HOLLAND - Marblehead MA, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
A61M 37/00, A61B 6/00, A61B 18/14
US Classification:
600431, 606 41, 604 20
Abstract:
Methods and systems are described that reduce risks of hematologic, metabolic, and renal complications in a mammal, such as a human, undergoing tissue ablation. One such method includes inserting a probe into a mammal and ablating abnormal tissue in the mammal by emitting a first amount of energy from the probe. In some embodiments, after emitting the first amount of energy, a method can include denaturing proteins released from cells in the abnormal tissue by emitting a second amount of energy from at least one of the first probe or a second probe inserted into the mammal. Furthermore, some embodiments can be implemented such that during or after the emitting the energy from a probe, a composition is administered to the mammal in an effective amount to denature proteins released from cells in the abnormal tissue.